Quest Diagnostics
As on 03 Apr, 2026 | 01:29 IST
| Open | 197.42 |
| Previous Close | 197.69 |
| Beta | -0.02 |
| High | 198.90 |
| Low | 196.06 |
| TTM EPS See historical trend | 9.85(+10.43% YoY) |
| 52 Week High | 213.50 |
| 52 Week Low | 157.20 |
| TTM PE See historical trend | 20.10(High PE) |
| Mkt. Cap ($ Billion) | 22.10 |
| Dividend Yield | 1.84 |
Advanced Chart
*Delayed by 20 seconds
MC Technicals
| Days | |
|---|---|
| 5 | 196.93 |
| 10 | 196.61 |
| 20 | 197.78 |
| 50 | 197.77 |
| 100 | 189.99 |
| 200 | 184.36 |
Returns
| 1 Week | 1.15% | |
| 1 Month | -6.50% | |
| 3 Months | 14.15% | |
| YTD | 14.15% | |
| 1 Year | 16.92% | |
| 3 Years | 39.96% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| UnitedHealth | 277.29 | 1.21 | 255.57 | 17.00 | 16.31 | 2.64 | 605.47/234.61 | -5.38 | Very Bearish |
| Thermo Fisher Scientific | 491.46 | -0.62 | 187.09 | 21.45 | 22.87 | 0.30 | 643.99/385.72 | -5.87 | Very Bullish |
| Danaher | 191.21 | 0.22 | 137.98 | 24.49 | 7.80 | 0.56 | 242.75/171.26 | -9.14 | Neutral |
| HCA | 471.84 | -0.61 | 124.79 | 16.70 | 28.26 | 0.62 | 556.52/314.43 | -10.77 | Very Bullish |
| McKesson | 884.35 | 1.38 | 116.21 | 23.53 | 37.58 | 0.37 | 998.98/637.00 | -10.22 | Very Bullish |
Market news
- Wall Street closes lower, posts weekly loss as war on Iran fuels inflation worriesMarch 14, 2026 8:59 AM
- US stocks close down as oil spikes 12%, job market weakensMarch 7, 2026 9:27 AM
- Wall Street ends higher after Supreme Court rules against Trump tariffsFebruary 21, 2026 8:06 AM
- S&P 500 ends up slightly as tech dips, inflation coolsFebruary 14, 2026 9:22 AM
About the company
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates under two segments: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services develops and delivers diagnostic testing information and services, providing insights that enables a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers, and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, and other brands, such as AmeriPath, Dermpath Diagnostics, ExamOne, Quanum. It also helps in delivering diagnostic insights for COVID-19 and a range of other medical conditions for communities in South Florida.